FDMT - 4D Molecular Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FDMT is currently covered by 7 analysts with an average price target of $37.43. This is a potential upside of $29.28 (359.26%) from yesterday's end of day stock price of $8.15.

4D Molecular Therapeutics 's activity chart (see below) currently has 11 price targets and 44 ratings on display. The stock rating distribution of FDMT is 94.59% BUY and 5.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.6% with an average time for these price targets to be met of 88.43 days.

Highest price target for FDMT is $81, Lowest price target is $36, average price target is $37.43.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Nov-2024. First documented stock forecast 05-Jan-2021.

Currently out of the existing stock ratings of FDMT, 35 are a BUY (94.59%), 2 are a HOLD (5.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$36

$27.17 (307.70%)

$36

6 days ago
(14-Nov-2024)

0/14 (0%)

$28.09 (355.12%)

Buy

$39

$30.17 (341.68%)

$40

6 days ago
(14-Nov-2024)

2/6 (33.33%)

$31.09 (393.05%)

29

Buy

1 months 28 days ago
(23-Sep-2024)

1/3 (33.33%)

$21.48 (204.18%)

104

Buy

$36

$27.17 (307.70%)

$24

2 months 1 days ago
(19-Sep-2024)

7/8 (87.5%)

$21.83 (154.06%)

285

Buy

$39

$30.17 (341.68%)

$38

2 months 1 days ago
(19-Sep-2024)

3/5 (60%)

$24.83 (175.23%)

201

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?

On average it took 88.43 days on average for the stock forecasts to be realized with a an average price target met ratio 30.6

Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 12 ratings on FDMT

Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?

Salveen Richter with highest potential upside - $72.17

Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?

Josh Schimmer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?